Skip to content

The 2nd European Carotid Surgery Trial

The 2nd European Carotid Surgery Trial - ECST-2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46858
Enrollment
200
Registered
2013-09-25
Start date
2014-11-11
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid narrowing

Interventions

carotid revascularisation (endarterectomy or, in exceptional cases, stenting) + medication vs medication alone

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - > 18 years of age - symptomatic or asymptomatic atherosclerotic carotid stenosis equivalent to at least 50% measured using de NASCET method - CAR (carotid artery risk) score

Exclusion criteria

Exclusion criteria: - Modified Rankin score > 2 - previous endarterectomy or stent in the randomised artery - coronary artery bypass grafting within 3 months prior to randomisation or other major surgery within 6 weeks prior to randomisation - coronary artery bypass grafting or other major surgery planned within 6 weeks randomisation - pregnancy - life expectancy of less than two years due to a pre-existing condition e.g. cancer.

Design outcomes

Primary

MeasureTime frame
Any stroke at any time, plus non-stroke death occurring within 30 days of revascularisation

Secondary

MeasureTime frame
- Ipsilateral stroke - myocardial infarction or any hospitalisation for - vascular disease during follow up. - Disabling stroke during follow up. - New cerebral infarction or haemorrhage on post procedural MRI. - Cognitive impairment. - Further treatment procedure. - Adverse events attributed to medical treatment or CEA. - Quality of life and economic measures.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)